CIK 0000875320
- Large accelerated filer
VERTEX PHARMACEUTICALS INC / MA
Sign in to watch- Ticker
- VRTX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- MA
- Entity type
- Operating
- EIN
- 043039129
- Phone
- +1 617-341-6393
- Business address
- 50 NORTHERN AVENUE, BOSTON, MA, 02210
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $15,378,206
- in 4 filings, $15.4M under 10b5-1 plans
Net −$15,378,206. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-24 | Kewalramani Reshma CEO & President | Shares withheld for taxes | −9,386 | $289.12 | $2.7M | 129,969 |
| 2023-02-24 | Bozic Carmen EVP and CMO | Shares withheld for taxes | −3,308 | $289.12 | $956K | 63,207 |
| 2023-02-24 | Arbuckle Stuart A EVP, COO | Shares withheld for taxes | −4,714 | $289.12 | $1.4M | 61,590 |
| 2023-02-24 | Ambrose Kristen SVP & Chief Accounting Officer | Shares withheld for taxes | −502 | $289.12 | $145K | 8,510 |
| 2023-02-24 | ALTSHULER DAVID EVP, Global Research and CSO | Shares withheld for taxes | −3,970 | $289.12 | $1.1M | 36,276 |
| 2023-02-22 | Arbuckle Stuart A EVP, COO | Sale | −129 | $291.84 | $38K | 68,576 |
| 2023-02-22 | Arbuckle Stuart A EVP, COO | Sale | −300 | $292.86 | $88K | 68,276 |
| 2023-02-22 | Arbuckle Stuart A EVP, COO | Sale | −1,378 | $294.29 | $406K | 66,898 |
| 2023-02-22 | Arbuckle Stuart A EVP, COO | Sale | −394 | $295.38 | $116K | 66,504 |
| 2023-02-22 | Arbuckle Stuart A EVP, COO | Sale | −200 | $296.31 | $59K | 66,304 |
| 2023-02-21 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale | −4 | $291.01 | $1K | 60,943 |
| 2023-02-21 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale | −145 | $292.85 | $42K | 60,798 |
| 2023-02-21 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale | −207 | $293.83 | $61K | 60,591 |
| 2023-02-21 | Tatsis Ourania EVP, Chief Reg. & Quality Off. | Sale | −124 | $294.77 | $37K | 60,467 |
| 2023-02-21 | Arbuckle Stuart A EVP, COO | Sale | −21 | $291.01 | $6K | 71,086 |
| 2023-02-21 | Arbuckle Stuart A EVP, COO | Sale | −545 | $292.77 | $160K | 70,541 |
| 2023-02-21 | Arbuckle Stuart A EVP, COO | Sale | −1,100 | $293.74 | $323K | 69,441 |
| 2023-02-21 | Arbuckle Stuart A EVP, COO | Sale | −736 | $294.58 | $217K | 68,705 |
| 2023-02-21 | ALTSHULER DAVID EVP, Global Research and CSO | Sale | −36 | $291.01 | $10K | 44,212 |
| 2023-02-21 | ALTSHULER DAVID EVP, Global Research and CSO | Sale | −1,223 | $292.76 | $358K | 42,989 |
Page 34 of 40 · 781 trades